Finance

Beta
Lists
DMRA:NASDAQ
Damora Therapeutics Inc
$20.15
-3.86%
(-0.81) 1D
Jun 10, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for DMRA...
Open
$20.98
High
$21.62
Low
$18.59
Mkt. cap
1.24B
Avg. vol.
361.38K
Volume
531.78K
52-wk high
$29.22
52-wk low
$16.50
EPS
-$141.43
Beta
1.46
Shares outstanding
61.55M
No. of employees
7
Open
$20.98
High
$21.62
Low
$18.59
Mkt. cap
1.24B
Avg. vol.
361.38K
Volume
531.78K
52-wk high
$29.22
52-wk low
$16.50
EPS
-$141.43
Beta
1.46
Shares outstanding
61.55M
No. of employees
7
Analyst outlook
Analyst Ratings
Based on 7 analysts giving stock ratings to DMRA in the past 3 months
Strong Buy
Buy
7
Hold
0
Sell
0
12 month forecast
Based on 7 Wall Street analysts offering 12 month price targets for DMRA in the last 3 months.
Highest
Current $20.15
$51.00 (+153.10%)
Average
$42.83 (+112.56%)
Lowest
$35.00 (+73.70%)
News stories
From sources across the web
About Damora Therapeutics Inc
CEO-
Employees7
Founded2011
HeadquartersWaltham, Massachusetts, United States
SectorBiotechnology
Websitedamoratx.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1.46M
1.42M
23.32M
23.78M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.96M
1.74M
4.07M
7.03M
Operating expense
3.42M
3.16M
27.39M
30.81M
Total operating expenses
3.42M
3.16M
27.39M
30.81M
Operating income
-3.42M
-3.16M
-27.39M
-30.81M
Other non operating income
-
-
-
-
EBT including unusual items
-3.43M
-3.13M
-200.69M
-27.74M
EBT excluding unusual items
-3.43M
-3.13M
-26.38M
-27.74M
Income tax expense
4.00K
-
44.00K
42.00K
Effective tax rate
-0.12%
-
-0.02%
-0.15%
Other operating expenses
-
-
-
-
Net income
-3.44M
-3.13M
-200.74M
-27.78M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-0.62
Interest and investment income
50.00K
42.00K
1.00M
3.07M
Interest expense
-
-
-
-
Net interest expenses
50.00K
42.00K
1.00M
3.07M
Depreciation and amortization charges
-
-
-
-
EBITDA
-3.42M
-3.15M
-27.38M
-30.81M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer